| Breast Cancer |
1 |
1 |
| Selective Estrogen Receptor Modulators |
0 |
0.62 |
| HER2-Negative Breast Cancer |
0 |
0.99 |
| Tumor |
0 |
0.53 |
| Breast |
0 |
0.46 |
| Cancer |
0 |
0.46 |
| Lymph Node |
0 |
0.14 |
| Receptors |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Clinical Research |
0 |
0.07 |
| Estrogen |
0 |
0.07 |
| Adjuvant Therapy |
0 |
0.04 |
| Aromatase Inhibitors |
0 |
0.04 |
| Disease Management |
0 |
0.04 |
| Tissue |
0 |
0.04 |